Antihypertensive Effects of SGLT2-Inhibitors: Considerations for
Clinical Practice

Andrea      Da Porto; Luca      Bulfone; Leonardo      Sechi

doi:10.2174/0115701611274645231208102130

Rights & Permissions Print Cite

Current Vascular Pharmacology

Title:Antihypertensive Effects of SGLT2-Inhibitors: Considerations for Clinical Practice

Volume: 22 Issue: 4

Author(s): Andrea Da Porto*, Luca Bulfone and Leonardo Sechi

Affiliation:

Diabetes and Metabolism Unit, Clinica Medica, University of Udine, Italy

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Da Porto Andrea*, Bulfone Luca and Sechi Leonardo, Antihypertensive Effects of SGLT2-Inhibitors: Considerations for Clinical Practice, Current Vascular Pharmacology 2024; 22 (4) . https://dx.doi.org/10.2174/0115701611274645231208102130

DOI https://dx.doi.org/10.2174/0115701611274645231208102130	Print ISSN 1570-1611
Publisher Name Bentham Science Publisher	Online ISSN 1875-6212

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 January, 2025

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more

Guest Editor(s): Stefanos Roumeliotis